UNSPSC 51386002: Bifeprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C22H25ClN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9973I7EX5X, chemically known as ( -)-2-chloro-alpha-methyl-4-biphenylacetic acid, ester with 1-glycoloyl-4-methyllpiperazine but generally known as bifeprofen, which bears US NIH Compound Identifier 185459. European Medicines Agency schedules Bifeprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05829MIG.

UNSPSC 51386002 Bifeprofen is a Commodity code that in practice sees minimal state and local procurement activity aligned with its nominal pharmaceutical scope. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS—is actually for naloxone and safe drug deactivation systems, not bifeprofen, indicating a significant mismatch between the code's assigned classification and the work being purchased. State and local procurement offices appear to use this code infrequently or incorrectly when categorizing pharmaceutical and medical product buys. The opportunity that does appear under the code requires quarterly deliveries of naloxone units and drug deactivation systems to support community health initiatives, with vendors responsible for all shipping and delivery costs and subject to E-Verify compliance, drug-free workplace certification, and standard insurance requirements including workers' compensation and commercial general liability.

Seminole County, Florida is the sole identifiable recent issuer under this code. The naloxone and drug deactivation systems procurement was released as an IFB on July 10, 2023, with a response deadline of July 26, 2023, and included a two-year initial term with a one-year renewal option, though the posting date of June 30, 2026 and the bid deadline of July 26, 2023 suggest potential data inconsistency in the source record. The contract was potentially funded through FEMA, which layered additional federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act. Given the minimal activity and the classification mismatch, this code does not represent an active procurement channel for firms focused on bifeprofen or closely related pharmaceutical products at the state and local level.